The combined market capitalisation of the companies promoted by the Singh brothers, Malvinder and Shivinder, is now down to Rs 83 billion from nearly Rs 206 billion on the eve of the Ranbaxy sale.
Many believe that bioequivalence testing is necessary for only a handful of medications. In reality, it should be the norm for virtually all drugs.
India needs a domestic pharmaceutical industry that is unfettered by foreign dominion and control, particularly by a rapacious multinational industry that so consistently prioritises supra profits for its executives.
A $48-billion (Rs 3.26 lakh crore) penalty claimed by the US government from Volkswagen for cheating on diesel-car emissions is about 200 times as large as the $225 million (Rs 1,500 crore) insurance pool set up by Indian insurance companies to compensate US nuclear companies for mishaps in […]
The commerce minister and the pharma industry lobby used smoke and mirrors to change the narrative
How systemic problems at a drug testing lab, GVK Bio, morphed into the story of an illicit affair.
The [Modi government] appears to rely heavily on the bureaucracy for policy guidance, rather than demanding that civil servants put the political leaders’ ideas into effect. This was a conclusion drawn by a report published in July this year by the Hudson Institute, titled “Modi one year on”. […]